In order to meet the needs of the development of clinical medicine in Chengdu, promote the leap-forward development of cardiovascular disease diagnosis and treatment in the Greater Chengdu area, and further improve the diagnosis and treatment of cardiovascular diseases in our province, on November 6, it was hosted by the Chengdu High-tech Medical Association. The inaugural meeting of the Cardiovascular Specialty Committee of the Chengdu High-tech Medical Association and the first seminar on new advances in cardiovascular disease diagnosis and treatment hosted by the First People’s Hospital was successfully held in Chengdu. The meeting adopted offline combined with online live broadcast, and a total of more than 5,000 people Watch.
On the morning of November 6, 2021, 65 experts from major hospitals in the province attended the inaugural meeting of the special committee online. According to the agenda and election procedures of the inaugural meeting, the meeting democratically elected members of the Standing Committee, chairmen, and Leading groups such as the chairman-designate and vice-chairmen. Director Zhang Jun of Chengdu First People’s Hospital was elected as the chairperson, Director Xie Wen of the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine was elected chairperson-designate, Sichuan Provincial People’s Hospital Li Gang, Chengdu Third People’s Hospital Wu Jing, Chengdu First People’s Hospital The hospital Chen Xinyun, Chengdu Second People's Hospital Hu Yongmei, Chengdu First People's Hospital Qin Fang, and Chengdu Seventh People's Hospital Shi Weichen were elected as deputy chairmen.
Health is an inevitable requirement for the all-round development of mankind, a basic condition for economic and social development, an important symbol of national prosperity and a country’s prosperity, and the common pursuit of the broad masses of people. Cardiovascular disease is a chronic disease of concern to all people. Against the background, the convening of this conference allows experts and scholars to grasp the latest new technologies and new developments in cardiovascular diagnosis and treatment through academic exchanges, strengthen communication among colleagues, and further improve the medical level of medical staff and treat patients with various cardiovascular diseases. At the same time, I hope that through the platform of the High-tech Medical Association, all cardiovascular doctors will cooperate sincerely, form a joint force, meet each other, and jointly improve the overall level of cardiovascular treatment and prevention in our province.